[6-K] INLIF Ltd Current Report (Foreign Issuer)
Rhea-AI Filing Summary
INLIF Limited reported it received a Nasdaq notice for not meeting the $1.00 minimum bid price after 30 consecutive business days between September 11 and October 24, 2025. The shares continue to trade on Nasdaq under “INLF,” and business operations are unaffected.
The company has 180 calendar days, until April 27, 2026, to regain compliance. If the closing bid price is at least $1.00 for 10 consecutive business days within this window, Nasdaq will confirm compliance. If needed, INLIF may be eligible for an additional 180-day period, subject to meeting other listing standards and notifying Nasdaq of plans to cure, which could include a reverse stock split.
Positive
- None.
Negative
- None.
Insights
Nasdaq bid-price deficiency disclosed; 180-day cure window in place.
INLIF fell below Nasdaq’s $1.00 minimum bid requirement over a 30-day period and received a deficiency notice. Trading continues under “INLF,” and the company states operations are not affected. This is a procedural step that starts a defined cure timeline.
The rule provides April 27, 2026 as the end of the initial 180-day window. Regaining compliance requires a closing bid at or above $1.00 for 10 consecutive business days. If unmet, a second 180-day window may be available if other initial listing standards are satisfied and the company notifies Nasdaq of its cure plan, potentially including a reverse split.
Key dependencies are market price performance and eligibility for the second window. Actual outcomes depend on share price behavior; the company has stated it will monitor the bid and evaluate options consistent with the rules.
FAQ
What did INLIF (INLF) disclose about its Nasdaq listing status?
Will INLIF (INLF) be delisted immediately?
How long does INLIF have to regain compliance with the bid price rule?
What must occur for INLIF to regain compliance within the initial period?
Can INLIF get more time if it doesn’t regain compliance by April 27, 2026?
Could INLIF use a reverse stock split to address the deficiency?